**Core Concept**
Tocilizumab is a biologic medication used to treat rheumatoid arthritis by targeting a specific cytokine involved in the inflammatory process. This cytokine plays a crucial role in the pathogenesis of rheumatoid arthritis by promoting inflammation and joint damage.

**Why the Correct Answer is Right**
Tocilizumab is a monoclonal antibody that specifically binds to interleukin-6 (IL-6), a pro-inflammatory cytokine produced by T cells and macrophages. IL-6 is a key mediator of inflammation and is involved in the regulation of immune responses. By binding to IL-6, tocilizumab inhibits its interaction with its receptor, thereby reducing inflammation and joint damage in patients with rheumatoid arthritis. This mechanism of action is critical in the treatment of rheumatoid arthritis, as IL-6 has been shown to contribute to the disease's pathogenesis.

**Why Each Wrong Option is Incorrect**
**Option A:** Not applicable, as this option is the correct answer.
**Option B:** Incorrect, as tocilizumab targets the cytokine itself, not its receptor. Although the IL-6 receptor is also involved in the inflammatory process, tocilizumab's mechanism of action is through cytokine inhibition.
**Option C:** Incorrect, as tocilizumab is not used against interleukin-5, which is involved in eosinophilic inflammation and asthma.
**Option D:** Incorrect, as tocilizumab targets the cytokine, not its receptor.

**Clinical Pearl / High-Yield Fact**
Tocilizumab's mechanism of action highlights the importance of IL-6 in the inflammatory process, making it a critical target for the treatment of rheumatoid arthritis. This knowledge can be applied to other conditions where IL-6 is involved, such as Castleman's disease and multiple myeloma.

✓ Correct Answer: A. Interleukin-6